Oleg V Tcheremissine1, J Octavio Salazar. 1. Behavioral Health Center-Carolinas Medical Center, Department of Psychiatry, 501 Billingsley Road, Charlotte, NC 28211, USA. oleg.tcheremissine@carolinas.org
Abstract
BACKGROUND: Attention deficit/hyperactivity disorder (ADHD) is the most commonly diagnosed psychiatric disorder in children and adolescents with well-known clinical consequences and functional outcomes that affect individuals throughout their lifespan. The diagnosis of adult ADHD is often a clinical diagnosis made on the basis of behavioral symptoms that begin early in life, and persist over time across different settings. OBJECTIVE: Although pharmacotherapy is a first-line treatment option for ADHD across all age groups, there is a relative paucity of well-designed and well-controlled studies evaluating the treatment outcomes in adult ADHD. In this review, evidence-based pharmacotherapy of adult ADHD and directions of future research are critically examined. METHODS: A literature search from 1980 to 2007, restricting papers to English, using PUBMED and PsychInfo was performed. Studies were examined based on empirically derived criteria. RESULTS: The reviewed body of evidence strongly supports the use of pharmacotherapy as a first-line therapeutic option for the treatment of adults with ADHD.
BACKGROUND:Attention deficit/hyperactivity disorder (ADHD) is the most commonly diagnosed psychiatric disorder in children and adolescents with well-known clinical consequences and functional outcomes that affect individuals throughout their lifespan. The diagnosis of adult ADHD is often a clinical diagnosis made on the basis of behavioral symptoms that begin early in life, and persist over time across different settings. OBJECTIVE: Although pharmacotherapy is a first-line treatment option for ADHD across all age groups, there is a relative paucity of well-designed and well-controlled studies evaluating the treatment outcomes in adult ADHD. In this review, evidence-based pharmacotherapy of adult ADHD and directions of future research are critically examined. METHODS: A literature search from 1980 to 2007, restricting papers to English, using PUBMED and PsychInfo was performed. Studies were examined based on empirically derived criteria. RESULTS: The reviewed body of evidence strongly supports the use of pharmacotherapy as a first-line therapeutic option for the treatment of adults with ADHD.
Authors: Maarit Virta; Anita Salakari; Mervi Antila; Esa Chydenius; Markku Partinen; Markus Kaski; Risto Vataja; Hely Kalska; Matti Iivanainen Journal: Neuropsychiatr Dis Treat Date: 2010-09-07 Impact factor: 2.570
Authors: Martin A Katzman; Timothy S Bilkey; Pratap R Chokka; Angelo Fallu; Larry J Klassen Journal: BMC Psychiatry Date: 2017-08-22 Impact factor: 3.630